Injectable lenacapavir – LEN, for short – is a highly effective, long-acting antiretroviral alternative to daily oral pills and other shorter-acting options, according to the World Health Organization (WHO). “While an HIV vaccine remains elusive, lenacapavir is the next best thing: a long-acting antiretroviral shown in trials to prevent almost...
The waiver allows the continuation or resumption of “life-saving humanitarian assistance” including HIV treatment. That means 20 million people living with HIV and whose medication is funded by the US can continue to receive treatment. “That’s 20 million out of the 30 million people living with HIV in the world,” said...
Subscribe
A customizable subscription slide-in box to promote your newsletter
[mc4wp_form id="128"]